{"id":"301","presentation":"304 - Survival in Intermacs 1 & 2 Patients After LVAD Therapy: Does Chronicity of Heart Failure Matter?","session":"ORAL SESSION 27 - How Sick is Too Sick? The Impact of Frailty and Cognitive Function in LVADs","filename":"ISHLT_Acute vs Chronic HF in Intermacs 1 and 2 Patients_Rame Final.pptx","speaker":"G. Troutman<small>, Philadelphia, PA, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt2018\/301\/jpg\/ishlt_acutevschronichfinintermacs1and2patients_ramefinal\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E5947\/session_token\/83bd8187ad02e3344efefc852c8217b5","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]